Medical Devices & Consumables
Global Blood Oxygenator Market Research Report 2026
- Nov 14, 26
- ID: 760825
- Pages: 121
- Figures: 126
- Views: 13
The global Blood Oxygenator market was valued at US$ 880 million in 2025 and is anticipated to reach US$ 1356 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Blood Oxygenator is a sterile, single-use extracorporeal blood-gas exchange device used to oxygenate venous blood and remove carbon dioxide during extracorporeal circulation. Modern Blood Oxygenator products are predominantly based on hollow-fiber membrane technology, with microporous polypropylene membranes widely used in conventional cardiopulmonary bypass and polymethylpentene membranes increasingly applied in prolonged extracorporeal respiratory or cardiopulmonary support. Product design is differentiated by rated blood flow, membrane surface area, priming volume, blood-side pressure drop, gas-transfer efficiency, heat-exchange performance, patient population, surface treatment and intended support duration. Advanced configurations may integrate heat exchange, arterial filtration, venous or cardiotomy reservoirs and monitoring functions into the Blood Oxygenator module. The principal clinical applications are cardiopulmonary bypass during cardiac surgery and prolonged extracorporeal life support, including extracorporeal membrane oxygenation, with dedicated product configurations for adult, pediatric and neonatal patients.
Key Findings
Cardiopulmonary bypass remains the largest routine application for Blood Oxygenator products by procedure-driven unit demand
Long-duration extracorporeal support is increasing the strategic importance of polymethylpentene membrane Blood Oxygenator products
Low priming volume, hemocompatible surfaces and integrated filtration are becoming key differentiators in advanced Blood Oxygenator design
Competition increasingly depends on membrane technology, perfusion platforms, disposable portfolios, regulatory capability and clinical channel depth
Market Trends
Blood Oxygenator development is moving from isolated gas-exchange performance toward integrated optimization of blood compatibility, circuit simplicity, durability and real-time device management. In cardiopulmonary bypass, product development increasingly emphasizes lower priming volume, reduced blood-side pressure drop, compact flow paths and integrated arterial filtration, helping perfusion teams reduce circuit complexity while maintaining gas-transfer efficiency. For prolonged extracorporeal support, membrane durability, lower plasma leakage, stable oxygen and carbon dioxide exchange and improved thromboresistance are becoming more important, supporting wider adoption of polymethylpentene-based designs. Surface technologies are also evolving from conventional untreated blood-contact pathways toward proprietary polymer, phosphorylcholine, heparin-based and other hemocompatible treatments. A further direction is the integration of pressure, temperature and oxygen-saturation sensing into the Blood Oxygenator module, shifting selected products toward digitally monitored components within broader extracorporeal life-support platforms.
Market Dynamics
Drivers
Blood Oxygenator demand benefits from a recurring consumable model because cardiopulmonary bypass and extracorporeal life-support procedures require dedicated disposable blood-gas exchange components. Cardiac surgery remains the foundational demand source, supported by coronary, valvular, congenital and other procedures requiring extracorporeal circulation. At the same time, the expansion of advanced intensive-care capabilities is increasing the number of hospitals able to provide prolonged extracorporeal respiratory and cardiopulmonary support. Product upgrading also contributes to value growth, as hospitals increasingly prioritize lower priming volume, stable gas exchange, reduced blood trauma, improved hemocompatibility and simplified circuit management. Manufacturers with established perfusion or extracorporeal support platforms can further reinforce recurring disposable demand through compatibility with installed equipment and standardized clinical workflows.
Restraints
Blood Oxygenator manufacturing requires precise control of hollow-fiber membranes, potting, blood-contact polymers, flow-path geometry, surface treatment, heat exchange, sterilization and quality assurance. Gas-transfer efficiency must remain consistent across changing flow conditions while pressure drop, hemolysis, thrombogenicity and leakage risks remain tightly controlled, creating substantial technical and regulatory barriers. Hospital purchasing systems can also exert pricing pressure on mature cardiopulmonary bypass products, particularly where competitive products provide similar baseline performance. In prolonged extracorporeal support, adoption depends on highly trained clinical teams, intensive-care infrastructure and institutional treatment protocols, limiting penetration in healthcare systems with insufficient perfusion and critical-care capacity.
Opportunities
The most attractive opportunities are developing around long-duration extracorporeal support, high-performance membrane materials, hemocompatible coatings, low-prime designs and integrated monitoring. Product innovation that extends stable blood-gas exchange while reducing plasma leakage, pressure loss and thrombotic risk can create meaningful differentiation in prolonged support. Pediatric and neonatal Blood Oxygenator products also remain technically demanding because low extracorporeal volume and precise flow management impose stricter design requirements than standard adult applications. In large emerging healthcare markets, localization of critical extracorporeal devices creates opportunities for manufacturers capable of combining regulatory compliance, manufacturing consistency and cost competitiveness. Integration of monitoring functions with Blood Oxygenator modules may further increase product value and strengthen connectivity with next-generation extracorporeal support systems.
Challenges
The principal technical challenge is balancing multiple performance objectives within a compact disposable device. Reducing priming volume and blood-contact surface area can conflict with requirements for membrane area, gas-transfer capacity and pressure control, while prolonged operation increases demands on membrane integrity, coating stability and thromboresistance. Specialized hollow-fiber materials and medical-grade components create supply-chain dependencies, and quality deviations can have direct clinical and regulatory consequences. Competitive dynamics are also becoming more complex as established cardiopulmonary companies, extracorporeal life-support platform suppliers and emerging domestic manufacturers expand across overlapping product categories. Commercial success therefore increasingly requires not only device performance, but also regulatory execution, manufacturing scale, hospital access, clinical training and reliable product availability.
Industry Chain Analysis
The upstream Blood Oxygenator industry is built around hollow-fiber membrane materials, medical-grade polymer housings, potting compounds, heat-exchange components, arterial filtration media, surface-treatment materials, connectors and selected embedded sensors. Microporous polypropylene remains important in conventional cardiopulmonary bypass, while polymethylpentene has greater strategic relevance in prolonged extracorporeal support because of its suitability for sustained gas exchange and lower plasma leakage. Manufacturing requires membrane-bundle formation, controlled fiber potting, precision molding, blood-flow-path engineering, coating application, assembly, sterilization and extensive performance testing. Value creation is therefore concentrated not only in raw materials but also in membrane engineering, flow dynamics, blood compatibility and reproducible manufacturing.
Midstream manufacturers increasingly compete through integrated perfusion and extracorporeal support portfolios rather than stand-alone Blood Oxygenator products alone. Integration of heat exchangers, arterial filters, reservoirs, specialized coatings and monitoring features can raise product value while reducing circuit complexity for users. Downstream demand is concentrated in cardiac surgery centers, perfusion departments, intensive-care units and extracorporeal life-support programs. Because Blood Oxygenator products are disposable, procedure volumes translate directly into recurring consumption, while compatibility with heart-lung machines, pumps, tubing sets and extracorporeal support platforms can strengthen customer retention. The industry's margin structure is consequently influenced by membrane and component sourcing, regulatory compliance, manufacturing yield, product integration, clinical support and the degree of direct hospital access.
Segment Insights
By clinical application, cardiopulmonary bypass Blood Oxygenator products remain the core unit-volume segment because cardiac surgery generates recurring and relatively predictable single-procedure demand. This segment has a mature hollow-fiber technology base and places strong emphasis on reliable gas exchange, low priming volume, compact circuit design and integration of heat exchangers, arterial filters and reservoirs. Adult Blood Oxygenator products account for the majority of routine clinical use, while pediatric and neonatal configurations form smaller but more technically specialized segments in which reduced priming volume, lower blood-contact area and precise flow management are particularly important.
Long-term extracorporeal support represents the more technology-intensive growth direction. Polymethylpentene membrane Blood Oxygenator products are increasingly important where prolonged support requires durable gas exchange and reduced plasma leakage. Hemocompatible surfaces, optimized flow paths and integrated monitoring further differentiate higher-value products. From a technology perspective, the competitive focus is shifting from gas-transfer capacity alone toward combined performance in blood compatibility, durability, pressure management, circuit simplification and monitoring. This creates opportunities for manufacturers capable of integrating membrane science, material engineering and system-level design rather than competing primarily on standard disposable specifications.
Downstream Market Opportunities
Cardiac surgery remains the principal downstream market for Blood Oxygenator products because cardiopulmonary bypass creates direct, recurring device consumption. Additional opportunity is increasingly associated with intensive-care applications requiring prolonged respiratory or cardiopulmonary support, where hospitals are building stronger extracorporeal life-support capabilities and demanding products with greater durability, lower thrombogenicity and simpler circuit management. Advanced tertiary hospitals remain the main users of high-performance products, while continued expansion of cardiac surgery and critical-care infrastructure in emerging markets broadens the addressable customer base. Pediatric cardiac surgery and neonatal extracorporeal support represent smaller-volume but higher-technical-barrier applications, making specialized low-prime and low-flow Blood Oxygenator products attractive niches for differentiated manufacturers.
Regional Insights
North America and Europe remain major high-value markets for Blood Oxygenator products, supported by mature cardiac surgery networks, established perfusion practice and extensive availability of extracorporeal life-support programs. Hospitals in these regions generally place greater weight on clinical evidence, regulatory compliance, blood compatibility, integrated circuit design and supplier service capabilities. Europe also maintains a substantial manufacturing and technology base in cardiopulmonary and extracorporeal support devices, supporting continued innovation in membrane systems, coatings, circuit integration and prolonged-support solutions.
Asia Pacific is becoming increasingly important from both demand and manufacturing perspectives. Japan has a mature domestic cardiopulmonary device industry with established Blood Oxygenator manufacturers and long-standing perfusion expertise. China is developing stronger domestic capabilities in membrane oxygenation and extracorporeal life-support systems as cardiac surgery capacity, critical-care infrastructure and localization of strategic medical devices continue to advance. South Korea has also begun developing domestic Blood Oxygenator technology, although commercial maturity remains lower than in Japan or China. Other Asian markets remain relatively dependent on imported devices, making regulatory access, distributor coverage, clinical education and dependable product supply important determinants of regional expansion.
Competitive Landscape Analysis
The Blood Oxygenator market is characterized by relatively high technical and regulatory barriers and a limited group of established manufacturers with meaningful cardiopulmonary or extracorporeal support capabilities. Medtronic plc, Terumo Corporation, LivaNova PLC and Getinge AB compete through broad perfusion platforms, global hospital relationships and complementary disposable portfolios. Fresenius Medical Care AG participates primarily through extracorporeal life-support solutions, while Eurosets S.r.l. has established a broad portfolio spanning conventional cardiopulmonary bypass and prolonged support. Nipro Corporation and SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. maintain established cardiopulmonary product capabilities with particular strength in Japan and selected international markets, while Spectrum Medical S.r.l. combines perfusion technologies with integrated monitoring and digital system capabilities. In China, Dongguan Kewei Medical Instrument Co., Ltd., Shenzhen Lifemotion Medical Technology Co., Ltd. and Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. represent the development of domestic Blood Oxygenator and extracorporeal life-support manufacturing. Competitive advantage increasingly depends on membrane durability, low-prime engineering, hemocompatible surfaces, integrated filtration, prolonged-support performance, monitoring capability, manufacturing consistency and access to specialized clinical channels rather than on gas-exchange specifications alone.
Report Scope
This report delivers a comprehensive overview of the global Blood Oxygenator market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood Oxygenator. The Blood Oxygenator market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blood Oxygenator market comprehensively. Regional market sizes by Type, by Application, by Support Duration, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blood Oxygenator manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic plc
Terumo Corporation
LivaNova PLC
Getinge AB
Fresenius Medical Care AG
Eurosets S.r.l.
Nipro Corporation
SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
Spectrum Medical S.r.l.
Dongguan Kewei Medical Instrument Co., Ltd.
Shenzhen Lifemotion Medical Technology Co., Ltd.
Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
Segment by Type
Cardiopulmonary Bypass Oxygenators
Extracorporeal Membrane Oxygenation Oxygenators
Others
Segment by Support Duration
Short-Term Oxygenators Up to 6 Hours
Long-Term Oxygenators Over 6 Hours
Segment by Membrane Material
Microporous Polypropylene Oxygenators
Polymethylpentene Oxygenators
Others
by Application
Adult Oxygenators
Pediatric and Neonatal Oxygenators
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Support Duration, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Blood Oxygenator manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Blood Oxygenator sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Blood Oxygenator is a sterile, single-use extracorporeal blood-gas exchange device used to oxygenate venous blood and remove carbon dioxide during extracorporeal circulation. Modern Blood Oxygenator products are predominantly based on hollow-fiber membrane technology, with microporous polypropylene membranes widely used in conventional cardiopulmonary bypass and polymethylpentene membranes increasingly applied in prolonged extracorporeal respiratory or cardiopulmonary support. Product design is differentiated by rated blood flow, membrane surface area, priming volume, blood-side pressure drop, gas-transfer efficiency, heat-exchange performance, patient population, surface treatment and intended support duration. Advanced configurations may integrate heat exchange, arterial filtration, venous or cardiotomy reservoirs and monitoring functions into the Blood Oxygenator module. The principal clinical applications are cardiopulmonary bypass during cardiac surgery and prolonged extracorporeal life support, including extracorporeal membrane oxygenation, with dedicated product configurations for adult, pediatric and neonatal patients.
Key Findings
Cardiopulmonary bypass remains the largest routine application for Blood Oxygenator products by procedure-driven unit demand
Long-duration extracorporeal support is increasing the strategic importance of polymethylpentene membrane Blood Oxygenator products
Low priming volume, hemocompatible surfaces and integrated filtration are becoming key differentiators in advanced Blood Oxygenator design
Competition increasingly depends on membrane technology, perfusion platforms, disposable portfolios, regulatory capability and clinical channel depth
Market Trends
Blood Oxygenator development is moving from isolated gas-exchange performance toward integrated optimization of blood compatibility, circuit simplicity, durability and real-time device management. In cardiopulmonary bypass, product development increasingly emphasizes lower priming volume, reduced blood-side pressure drop, compact flow paths and integrated arterial filtration, helping perfusion teams reduce circuit complexity while maintaining gas-transfer efficiency. For prolonged extracorporeal support, membrane durability, lower plasma leakage, stable oxygen and carbon dioxide exchange and improved thromboresistance are becoming more important, supporting wider adoption of polymethylpentene-based designs. Surface technologies are also evolving from conventional untreated blood-contact pathways toward proprietary polymer, phosphorylcholine, heparin-based and other hemocompatible treatments. A further direction is the integration of pressure, temperature and oxygen-saturation sensing into the Blood Oxygenator module, shifting selected products toward digitally monitored components within broader extracorporeal life-support platforms.
Market Dynamics
Drivers
Blood Oxygenator demand benefits from a recurring consumable model because cardiopulmonary bypass and extracorporeal life-support procedures require dedicated disposable blood-gas exchange components. Cardiac surgery remains the foundational demand source, supported by coronary, valvular, congenital and other procedures requiring extracorporeal circulation. At the same time, the expansion of advanced intensive-care capabilities is increasing the number of hospitals able to provide prolonged extracorporeal respiratory and cardiopulmonary support. Product upgrading also contributes to value growth, as hospitals increasingly prioritize lower priming volume, stable gas exchange, reduced blood trauma, improved hemocompatibility and simplified circuit management. Manufacturers with established perfusion or extracorporeal support platforms can further reinforce recurring disposable demand through compatibility with installed equipment and standardized clinical workflows.
Restraints
Blood Oxygenator manufacturing requires precise control of hollow-fiber membranes, potting, blood-contact polymers, flow-path geometry, surface treatment, heat exchange, sterilization and quality assurance. Gas-transfer efficiency must remain consistent across changing flow conditions while pressure drop, hemolysis, thrombogenicity and leakage risks remain tightly controlled, creating substantial technical and regulatory barriers. Hospital purchasing systems can also exert pricing pressure on mature cardiopulmonary bypass products, particularly where competitive products provide similar baseline performance. In prolonged extracorporeal support, adoption depends on highly trained clinical teams, intensive-care infrastructure and institutional treatment protocols, limiting penetration in healthcare systems with insufficient perfusion and critical-care capacity.
Opportunities
The most attractive opportunities are developing around long-duration extracorporeal support, high-performance membrane materials, hemocompatible coatings, low-prime designs and integrated monitoring. Product innovation that extends stable blood-gas exchange while reducing plasma leakage, pressure loss and thrombotic risk can create meaningful differentiation in prolonged support. Pediatric and neonatal Blood Oxygenator products also remain technically demanding because low extracorporeal volume and precise flow management impose stricter design requirements than standard adult applications. In large emerging healthcare markets, localization of critical extracorporeal devices creates opportunities for manufacturers capable of combining regulatory compliance, manufacturing consistency and cost competitiveness. Integration of monitoring functions with Blood Oxygenator modules may further increase product value and strengthen connectivity with next-generation extracorporeal support systems.
Challenges
The principal technical challenge is balancing multiple performance objectives within a compact disposable device. Reducing priming volume and blood-contact surface area can conflict with requirements for membrane area, gas-transfer capacity and pressure control, while prolonged operation increases demands on membrane integrity, coating stability and thromboresistance. Specialized hollow-fiber materials and medical-grade components create supply-chain dependencies, and quality deviations can have direct clinical and regulatory consequences. Competitive dynamics are also becoming more complex as established cardiopulmonary companies, extracorporeal life-support platform suppliers and emerging domestic manufacturers expand across overlapping product categories. Commercial success therefore increasingly requires not only device performance, but also regulatory execution, manufacturing scale, hospital access, clinical training and reliable product availability.
Industry Chain Analysis
The upstream Blood Oxygenator industry is built around hollow-fiber membrane materials, medical-grade polymer housings, potting compounds, heat-exchange components, arterial filtration media, surface-treatment materials, connectors and selected embedded sensors. Microporous polypropylene remains important in conventional cardiopulmonary bypass, while polymethylpentene has greater strategic relevance in prolonged extracorporeal support because of its suitability for sustained gas exchange and lower plasma leakage. Manufacturing requires membrane-bundle formation, controlled fiber potting, precision molding, blood-flow-path engineering, coating application, assembly, sterilization and extensive performance testing. Value creation is therefore concentrated not only in raw materials but also in membrane engineering, flow dynamics, blood compatibility and reproducible manufacturing.
Midstream manufacturers increasingly compete through integrated perfusion and extracorporeal support portfolios rather than stand-alone Blood Oxygenator products alone. Integration of heat exchangers, arterial filters, reservoirs, specialized coatings and monitoring features can raise product value while reducing circuit complexity for users. Downstream demand is concentrated in cardiac surgery centers, perfusion departments, intensive-care units and extracorporeal life-support programs. Because Blood Oxygenator products are disposable, procedure volumes translate directly into recurring consumption, while compatibility with heart-lung machines, pumps, tubing sets and extracorporeal support platforms can strengthen customer retention. The industry's margin structure is consequently influenced by membrane and component sourcing, regulatory compliance, manufacturing yield, product integration, clinical support and the degree of direct hospital access.
Segment Insights
By clinical application, cardiopulmonary bypass Blood Oxygenator products remain the core unit-volume segment because cardiac surgery generates recurring and relatively predictable single-procedure demand. This segment has a mature hollow-fiber technology base and places strong emphasis on reliable gas exchange, low priming volume, compact circuit design and integration of heat exchangers, arterial filters and reservoirs. Adult Blood Oxygenator products account for the majority of routine clinical use, while pediatric and neonatal configurations form smaller but more technically specialized segments in which reduced priming volume, lower blood-contact area and precise flow management are particularly important.
Long-term extracorporeal support represents the more technology-intensive growth direction. Polymethylpentene membrane Blood Oxygenator products are increasingly important where prolonged support requires durable gas exchange and reduced plasma leakage. Hemocompatible surfaces, optimized flow paths and integrated monitoring further differentiate higher-value products. From a technology perspective, the competitive focus is shifting from gas-transfer capacity alone toward combined performance in blood compatibility, durability, pressure management, circuit simplification and monitoring. This creates opportunities for manufacturers capable of integrating membrane science, material engineering and system-level design rather than competing primarily on standard disposable specifications.
Downstream Market Opportunities
Cardiac surgery remains the principal downstream market for Blood Oxygenator products because cardiopulmonary bypass creates direct, recurring device consumption. Additional opportunity is increasingly associated with intensive-care applications requiring prolonged respiratory or cardiopulmonary support, where hospitals are building stronger extracorporeal life-support capabilities and demanding products with greater durability, lower thrombogenicity and simpler circuit management. Advanced tertiary hospitals remain the main users of high-performance products, while continued expansion of cardiac surgery and critical-care infrastructure in emerging markets broadens the addressable customer base. Pediatric cardiac surgery and neonatal extracorporeal support represent smaller-volume but higher-technical-barrier applications, making specialized low-prime and low-flow Blood Oxygenator products attractive niches for differentiated manufacturers.
Regional Insights
North America and Europe remain major high-value markets for Blood Oxygenator products, supported by mature cardiac surgery networks, established perfusion practice and extensive availability of extracorporeal life-support programs. Hospitals in these regions generally place greater weight on clinical evidence, regulatory compliance, blood compatibility, integrated circuit design and supplier service capabilities. Europe also maintains a substantial manufacturing and technology base in cardiopulmonary and extracorporeal support devices, supporting continued innovation in membrane systems, coatings, circuit integration and prolonged-support solutions.
Asia Pacific is becoming increasingly important from both demand and manufacturing perspectives. Japan has a mature domestic cardiopulmonary device industry with established Blood Oxygenator manufacturers and long-standing perfusion expertise. China is developing stronger domestic capabilities in membrane oxygenation and extracorporeal life-support systems as cardiac surgery capacity, critical-care infrastructure and localization of strategic medical devices continue to advance. South Korea has also begun developing domestic Blood Oxygenator technology, although commercial maturity remains lower than in Japan or China. Other Asian markets remain relatively dependent on imported devices, making regulatory access, distributor coverage, clinical education and dependable product supply important determinants of regional expansion.
Competitive Landscape Analysis
The Blood Oxygenator market is characterized by relatively high technical and regulatory barriers and a limited group of established manufacturers with meaningful cardiopulmonary or extracorporeal support capabilities. Medtronic plc, Terumo Corporation, LivaNova PLC and Getinge AB compete through broad perfusion platforms, global hospital relationships and complementary disposable portfolios. Fresenius Medical Care AG participates primarily through extracorporeal life-support solutions, while Eurosets S.r.l. has established a broad portfolio spanning conventional cardiopulmonary bypass and prolonged support. Nipro Corporation and SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. maintain established cardiopulmonary product capabilities with particular strength in Japan and selected international markets, while Spectrum Medical S.r.l. combines perfusion technologies with integrated monitoring and digital system capabilities. In China, Dongguan Kewei Medical Instrument Co., Ltd., Shenzhen Lifemotion Medical Technology Co., Ltd. and Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. represent the development of domestic Blood Oxygenator and extracorporeal life-support manufacturing. Competitive advantage increasingly depends on membrane durability, low-prime engineering, hemocompatible surfaces, integrated filtration, prolonged-support performance, monitoring capability, manufacturing consistency and access to specialized clinical channels rather than on gas-exchange specifications alone.
Report Scope
This report delivers a comprehensive overview of the global Blood Oxygenator market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood Oxygenator. The Blood Oxygenator market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blood Oxygenator market comprehensively. Regional market sizes by Type, by Application, by Support Duration, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blood Oxygenator manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic plc
Terumo Corporation
LivaNova PLC
Getinge AB
Fresenius Medical Care AG
Eurosets S.r.l.
Nipro Corporation
SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
Spectrum Medical S.r.l.
Dongguan Kewei Medical Instrument Co., Ltd.
Shenzhen Lifemotion Medical Technology Co., Ltd.
Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
Segment by Type
Cardiopulmonary Bypass Oxygenators
Extracorporeal Membrane Oxygenation Oxygenators
Others
Segment by Support Duration
Short-Term Oxygenators Up to 6 Hours
Long-Term Oxygenators Over 6 Hours
Segment by Membrane Material
Microporous Polypropylene Oxygenators
Polymethylpentene Oxygenators
Others
by Application
Adult Oxygenators
Pediatric and Neonatal Oxygenators
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Support Duration, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Blood Oxygenator manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Blood Oxygenator sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Blood Oxygenator Market Overview
1.1 Product Definition
1.2 Blood Oxygenator by Type
1.2.1 Global Blood Oxygenator Market Value by Type: 2025 vs 2032
1.2.2 Cardiopulmonary Bypass Oxygenators
1.2.3 Extracorporeal Membrane Oxygenation Oxygenators
1.2.4 Others
1.3 Blood Oxygenator by Support Duration
1.3.1 Global Blood Oxygenator Market Value by Support Duration: 2025 vs 2032
1.3.2 Short-Term Oxygenators Up to 6 Hours
1.3.3 Long-Term Oxygenators Over 6 Hours
1.4 Blood Oxygenator by Membrane Material
1.4.1 Global Blood Oxygenator Market Value by Membrane Material: 2025 vs 2032
1.4.2 Microporous Polypropylene Oxygenators
1.4.3 Polymethylpentene Oxygenators
1.4.4 Others
1.5 Blood Oxygenator by Application
1.5.1 Global Blood Oxygenator Market Value by Application: 2025 vs 2032
1.5.2 Adult Oxygenators
1.5.3 Pediatric and Neonatal Oxygenators
1.6 Global Blood Oxygenator Market Size Estimates and Forecasts
1.6.1 Global Blood Oxygenator Revenue 2021–2032
1.6.2 Global Blood Oxygenator Sales 2021–2032
1.6.3 Global Blood Oxygenator Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Blood Oxygenator Market Competition by Manufacturers
2.1 Global Blood Oxygenator Sales Market Share by Manufacturers (2021–2026)
2.2 Global Blood Oxygenator Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Blood Oxygenator Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Blood Oxygenator, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Blood Oxygenator, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Blood Oxygenator, Product Types and Applications
2.7 Global Key Manufacturers of Blood Oxygenator, Date of Entry into the Industry
2.8 Global Blood Oxygenator Market Competitive Situation and Trends
2.8.1 Global Blood Oxygenator Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Blood Oxygenator Players Market Share by Revenue
2.8.3 Global Blood Oxygenator Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood Oxygenator Market Scenario by Region
3.1 Global Blood Oxygenator Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Blood Oxygenator Sales by Region: 2021–2032
3.2.1 Global Blood Oxygenator Sales by Region: 2021–2026
3.2.2 Global Blood Oxygenator Sales by Region: 2027–2032
3.3 Global Blood Oxygenator Revenue by Region: 2021–2032
3.3.1 Global Blood Oxygenator Revenue by Region: 2021–2026
3.3.2 Global Blood Oxygenator Revenue by Region: 2027–2032
3.4 North America Blood Oxygenator Market Facts & Figures by Country
3.4.1 North America Blood Oxygenator Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Blood Oxygenator Sales by Country (2021–2032)
3.4.3 North America Blood Oxygenator Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Blood Oxygenator Market Facts & Figures by Country
3.5.1 Europe Blood Oxygenator Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Blood Oxygenator Sales by Country (2021–2032)
3.5.3 Europe Blood Oxygenator Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Oxygenator Market Facts & Figures by Region
3.6.1 Asia Pacific Blood Oxygenator Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Blood Oxygenator Sales by Region (2021–2032)
3.6.3 Asia Pacific Blood Oxygenator Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Blood Oxygenator Market Facts & Figures by Country
3.7.1 Latin America Blood Oxygenator Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Blood Oxygenator Sales by Country (2021–2032)
3.7.3 Latin America Blood Oxygenator Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Oxygenator Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Oxygenator Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Blood Oxygenator Sales by Country (2021–2032)
3.8.3 Middle East and Africa Blood Oxygenator Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Blood Oxygenator Sales by Type (2021–2032)
4.1.1 Global Blood Oxygenator Sales by Type (2021–2026)
4.1.2 Global Blood Oxygenator Sales by Type (2027–2032)
4.1.3 Global Blood Oxygenator Sales Market Share by Type (2021–2032)
4.2 Global Blood Oxygenator Revenue by Type (2021–2032)
4.2.1 Global Blood Oxygenator Revenue by Type (2021–2026)
4.2.2 Global Blood Oxygenator Revenue by Type (2027–2032)
4.2.3 Global Blood Oxygenator Revenue Market Share by Type (2021–2032)
4.3 Global Blood Oxygenator Price by Type (2021–2032)
5 Segment by Application
5.1 Global Blood Oxygenator Sales by Application (2021–2032)
5.1.1 Global Blood Oxygenator Sales by Application (2021–2026)
5.1.2 Global Blood Oxygenator Sales by Application (2027–2032)
5.1.3 Global Blood Oxygenator Sales Market Share by Application (2021–2032)
5.2 Global Blood Oxygenator Revenue by Application (2021–2032)
5.2.1 Global Blood Oxygenator Revenue by Application (2021–2026)
5.2.2 Global Blood Oxygenator Revenue by Application (2027–2032)
5.2.3 Global Blood Oxygenator Revenue Market Share by Application (2021–2032)
5.3 Global Blood Oxygenator Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Company Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic plc Blood Oxygenator Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Terumo Corporation
6.2.1 Terumo Corporation Company Information
6.2.2 Terumo Corporation Description and Business Overview
6.2.3 Terumo Corporation Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo Corporation Blood Oxygenator Product Portfolio
6.2.5 Terumo Corporation Recent Developments/Updates
6.3 LivaNova PLC
6.3.1 LivaNova PLC Company Information
6.3.2 LivaNova PLC Description and Business Overview
6.3.3 LivaNova PLC Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 LivaNova PLC Blood Oxygenator Product Portfolio
6.3.5 LivaNova PLC Recent Developments/Updates
6.4 Getinge AB
6.4.1 Getinge AB Company Information
6.4.2 Getinge AB Description and Business Overview
6.4.3 Getinge AB Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Getinge AB Blood Oxygenator Product Portfolio
6.4.5 Getinge AB Recent Developments/Updates
6.5 Fresenius Medical Care AG
6.5.1 Fresenius Medical Care AG Company Information
6.5.2 Fresenius Medical Care AG Description and Business Overview
6.5.3 Fresenius Medical Care AG Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Medical Care AG Blood Oxygenator Product Portfolio
6.5.5 Fresenius Medical Care AG Recent Developments/Updates
6.6 Eurosets S.r.l.
6.6.1 Eurosets S.r.l. Company Information
6.6.2 Eurosets S.r.l. Description and Business Overview
6.6.3 Eurosets S.r.l. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Eurosets S.r.l. Blood Oxygenator Product Portfolio
6.6.5 Eurosets S.r.l. Recent Developments/Updates
6.7 Nipro Corporation
6.7.1 Nipro Corporation Company Information
6.7.2 Nipro Corporation Description and Business Overview
6.7.3 Nipro Corporation Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Nipro Corporation Blood Oxygenator Product Portfolio
6.7.5 Nipro Corporation Recent Developments/Updates
6.8 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
6.8.1 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Company Information
6.8.2 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Description and Business Overview
6.8.3 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood Oxygenator Product Portfolio
6.8.5 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Recent Developments/Updates
6.9 Spectrum Medical S.r.l.
6.9.1 Spectrum Medical S.r.l. Company Information
6.9.2 Spectrum Medical S.r.l. Description and Business Overview
6.9.3 Spectrum Medical S.r.l. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Spectrum Medical S.r.l. Blood Oxygenator Product Portfolio
6.9.5 Spectrum Medical S.r.l. Recent Developments/Updates
6.10 Dongguan Kewei Medical Instrument Co., Ltd.
6.10.1 Dongguan Kewei Medical Instrument Co., Ltd. Company Information
6.10.2 Dongguan Kewei Medical Instrument Co., Ltd. Description and Business Overview
6.10.3 Dongguan Kewei Medical Instrument Co., Ltd. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Dongguan Kewei Medical Instrument Co., Ltd. Blood Oxygenator Product Portfolio
6.10.5 Dongguan Kewei Medical Instrument Co., Ltd. Recent Developments/Updates
6.11 Shenzhen Lifemotion Medical Technology Co., Ltd.
6.11.1 Shenzhen Lifemotion Medical Technology Co., Ltd. Company Information
6.11.2 Shenzhen Lifemotion Medical Technology Co., Ltd. Description and Business Overview
6.11.3 Shenzhen Lifemotion Medical Technology Co., Ltd. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shenzhen Lifemotion Medical Technology Co., Ltd. Blood Oxygenator Product Portfolio
6.11.5 Shenzhen Lifemotion Medical Technology Co., Ltd. Recent Developments/Updates
6.12 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
6.12.1 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Company Information
6.12.2 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Description and Business Overview
6.12.3 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood Oxygenator Product Portfolio
6.12.5 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Oxygenator Industry Chain Analysis
7.2 Blood Oxygenator Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Oxygenator Production Mode & Process Analysis
7.4 Blood Oxygenator Sales and Marketing
7.4.1 Blood Oxygenator Sales Channels
7.4.2 Blood Oxygenator Distributors
7.5 Blood Oxygenator Customer Analysis
8 Blood Oxygenator Market Dynamics
8.1 Blood Oxygenator Industry Trends
8.2 Blood Oxygenator Market Drivers
8.3 Blood Oxygenator Market Challenges
8.4 Blood Oxygenator Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Blood Oxygenator by Type
1.2.1 Global Blood Oxygenator Market Value by Type: 2025 vs 2032
1.2.2 Cardiopulmonary Bypass Oxygenators
1.2.3 Extracorporeal Membrane Oxygenation Oxygenators
1.2.4 Others
1.3 Blood Oxygenator by Support Duration
1.3.1 Global Blood Oxygenator Market Value by Support Duration: 2025 vs 2032
1.3.2 Short-Term Oxygenators Up to 6 Hours
1.3.3 Long-Term Oxygenators Over 6 Hours
1.4 Blood Oxygenator by Membrane Material
1.4.1 Global Blood Oxygenator Market Value by Membrane Material: 2025 vs 2032
1.4.2 Microporous Polypropylene Oxygenators
1.4.3 Polymethylpentene Oxygenators
1.4.4 Others
1.5 Blood Oxygenator by Application
1.5.1 Global Blood Oxygenator Market Value by Application: 2025 vs 2032
1.5.2 Adult Oxygenators
1.5.3 Pediatric and Neonatal Oxygenators
1.6 Global Blood Oxygenator Market Size Estimates and Forecasts
1.6.1 Global Blood Oxygenator Revenue 2021–2032
1.6.2 Global Blood Oxygenator Sales 2021–2032
1.6.3 Global Blood Oxygenator Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Blood Oxygenator Market Competition by Manufacturers
2.1 Global Blood Oxygenator Sales Market Share by Manufacturers (2021–2026)
2.2 Global Blood Oxygenator Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Blood Oxygenator Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Blood Oxygenator, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Blood Oxygenator, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Blood Oxygenator, Product Types and Applications
2.7 Global Key Manufacturers of Blood Oxygenator, Date of Entry into the Industry
2.8 Global Blood Oxygenator Market Competitive Situation and Trends
2.8.1 Global Blood Oxygenator Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Blood Oxygenator Players Market Share by Revenue
2.8.3 Global Blood Oxygenator Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood Oxygenator Market Scenario by Region
3.1 Global Blood Oxygenator Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Blood Oxygenator Sales by Region: 2021–2032
3.2.1 Global Blood Oxygenator Sales by Region: 2021–2026
3.2.2 Global Blood Oxygenator Sales by Region: 2027–2032
3.3 Global Blood Oxygenator Revenue by Region: 2021–2032
3.3.1 Global Blood Oxygenator Revenue by Region: 2021–2026
3.3.2 Global Blood Oxygenator Revenue by Region: 2027–2032
3.4 North America Blood Oxygenator Market Facts & Figures by Country
3.4.1 North America Blood Oxygenator Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Blood Oxygenator Sales by Country (2021–2032)
3.4.3 North America Blood Oxygenator Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Blood Oxygenator Market Facts & Figures by Country
3.5.1 Europe Blood Oxygenator Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Blood Oxygenator Sales by Country (2021–2032)
3.5.3 Europe Blood Oxygenator Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Oxygenator Market Facts & Figures by Region
3.6.1 Asia Pacific Blood Oxygenator Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Blood Oxygenator Sales by Region (2021–2032)
3.6.3 Asia Pacific Blood Oxygenator Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Blood Oxygenator Market Facts & Figures by Country
3.7.1 Latin America Blood Oxygenator Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Blood Oxygenator Sales by Country (2021–2032)
3.7.3 Latin America Blood Oxygenator Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Oxygenator Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Oxygenator Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Blood Oxygenator Sales by Country (2021–2032)
3.8.3 Middle East and Africa Blood Oxygenator Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Blood Oxygenator Sales by Type (2021–2032)
4.1.1 Global Blood Oxygenator Sales by Type (2021–2026)
4.1.2 Global Blood Oxygenator Sales by Type (2027–2032)
4.1.3 Global Blood Oxygenator Sales Market Share by Type (2021–2032)
4.2 Global Blood Oxygenator Revenue by Type (2021–2032)
4.2.1 Global Blood Oxygenator Revenue by Type (2021–2026)
4.2.2 Global Blood Oxygenator Revenue by Type (2027–2032)
4.2.3 Global Blood Oxygenator Revenue Market Share by Type (2021–2032)
4.3 Global Blood Oxygenator Price by Type (2021–2032)
5 Segment by Application
5.1 Global Blood Oxygenator Sales by Application (2021–2032)
5.1.1 Global Blood Oxygenator Sales by Application (2021–2026)
5.1.2 Global Blood Oxygenator Sales by Application (2027–2032)
5.1.3 Global Blood Oxygenator Sales Market Share by Application (2021–2032)
5.2 Global Blood Oxygenator Revenue by Application (2021–2032)
5.2.1 Global Blood Oxygenator Revenue by Application (2021–2026)
5.2.2 Global Blood Oxygenator Revenue by Application (2027–2032)
5.2.3 Global Blood Oxygenator Revenue Market Share by Application (2021–2032)
5.3 Global Blood Oxygenator Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Company Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic plc Blood Oxygenator Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Terumo Corporation
6.2.1 Terumo Corporation Company Information
6.2.2 Terumo Corporation Description and Business Overview
6.2.3 Terumo Corporation Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo Corporation Blood Oxygenator Product Portfolio
6.2.5 Terumo Corporation Recent Developments/Updates
6.3 LivaNova PLC
6.3.1 LivaNova PLC Company Information
6.3.2 LivaNova PLC Description and Business Overview
6.3.3 LivaNova PLC Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 LivaNova PLC Blood Oxygenator Product Portfolio
6.3.5 LivaNova PLC Recent Developments/Updates
6.4 Getinge AB
6.4.1 Getinge AB Company Information
6.4.2 Getinge AB Description and Business Overview
6.4.3 Getinge AB Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Getinge AB Blood Oxygenator Product Portfolio
6.4.5 Getinge AB Recent Developments/Updates
6.5 Fresenius Medical Care AG
6.5.1 Fresenius Medical Care AG Company Information
6.5.2 Fresenius Medical Care AG Description and Business Overview
6.5.3 Fresenius Medical Care AG Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Medical Care AG Blood Oxygenator Product Portfolio
6.5.5 Fresenius Medical Care AG Recent Developments/Updates
6.6 Eurosets S.r.l.
6.6.1 Eurosets S.r.l. Company Information
6.6.2 Eurosets S.r.l. Description and Business Overview
6.6.3 Eurosets S.r.l. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Eurosets S.r.l. Blood Oxygenator Product Portfolio
6.6.5 Eurosets S.r.l. Recent Developments/Updates
6.7 Nipro Corporation
6.7.1 Nipro Corporation Company Information
6.7.2 Nipro Corporation Description and Business Overview
6.7.3 Nipro Corporation Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Nipro Corporation Blood Oxygenator Product Portfolio
6.7.5 Nipro Corporation Recent Developments/Updates
6.8 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
6.8.1 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Company Information
6.8.2 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Description and Business Overview
6.8.3 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood Oxygenator Product Portfolio
6.8.5 SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Recent Developments/Updates
6.9 Spectrum Medical S.r.l.
6.9.1 Spectrum Medical S.r.l. Company Information
6.9.2 Spectrum Medical S.r.l. Description and Business Overview
6.9.3 Spectrum Medical S.r.l. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Spectrum Medical S.r.l. Blood Oxygenator Product Portfolio
6.9.5 Spectrum Medical S.r.l. Recent Developments/Updates
6.10 Dongguan Kewei Medical Instrument Co., Ltd.
6.10.1 Dongguan Kewei Medical Instrument Co., Ltd. Company Information
6.10.2 Dongguan Kewei Medical Instrument Co., Ltd. Description and Business Overview
6.10.3 Dongguan Kewei Medical Instrument Co., Ltd. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Dongguan Kewei Medical Instrument Co., Ltd. Blood Oxygenator Product Portfolio
6.10.5 Dongguan Kewei Medical Instrument Co., Ltd. Recent Developments/Updates
6.11 Shenzhen Lifemotion Medical Technology Co., Ltd.
6.11.1 Shenzhen Lifemotion Medical Technology Co., Ltd. Company Information
6.11.2 Shenzhen Lifemotion Medical Technology Co., Ltd. Description and Business Overview
6.11.3 Shenzhen Lifemotion Medical Technology Co., Ltd. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shenzhen Lifemotion Medical Technology Co., Ltd. Blood Oxygenator Product Portfolio
6.11.5 Shenzhen Lifemotion Medical Technology Co., Ltd. Recent Developments/Updates
6.12 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd.
6.12.1 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Company Information
6.12.2 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Description and Business Overview
6.12.3 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood Oxygenator Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood Oxygenator Product Portfolio
6.12.5 Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Oxygenator Industry Chain Analysis
7.2 Blood Oxygenator Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Oxygenator Production Mode & Process Analysis
7.4 Blood Oxygenator Sales and Marketing
7.4.1 Blood Oxygenator Sales Channels
7.4.2 Blood Oxygenator Distributors
7.5 Blood Oxygenator Customer Analysis
8 Blood Oxygenator Market Dynamics
8.1 Blood Oxygenator Industry Trends
8.2 Blood Oxygenator Market Drivers
8.3 Blood Oxygenator Market Challenges
8.4 Blood Oxygenator Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Blood Oxygenator Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Blood Oxygenator Market Value by Support Duration (US$ Million), 2025 vs 2032
Table 3. Global Blood Oxygenator Market Value by Membrane Material (US$ Million), 2025 vs 2032
Table 4. Global Blood Oxygenator Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Blood Oxygenator Market Competitive Situation by Manufacturers in 2025
Table 6. Global Blood Oxygenator Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Blood Oxygenator Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Blood Oxygenator Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Blood Oxygenator Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Blood Oxygenator Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Blood Oxygenator, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Blood Oxygenator, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Blood Oxygenator, Product Types and Applications
Table 14. Global Key Manufacturers of Blood Oxygenator, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Blood Oxygenator Companies by Tier (Tier 1, Tier 2, Tier 3), based on Blood Oxygenator Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Blood Oxygenator Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Blood Oxygenator Sales by Region (Units), 2021–2026
Table 20. Global Blood Oxygenator Sales Market Share by Region (2021–2026)
Table 21. Global Blood Oxygenator Sales by Region (Units), 2027–2032
Table 22. Global Blood Oxygenator Sales Market Share by Region (2027–2032)
Table 23. Global Blood Oxygenator Revenue by Region (US$ Million), 2021–2026
Table 24. Global Blood Oxygenator Revenue Market Share by Region (2021–2026)
Table 25. Global Blood Oxygenator Revenue by Region (US$ Million), 2027–2032
Table 26. Global Blood Oxygenator Revenue Market Share by Region (2027–2032)
Table 27. North America Blood Oxygenator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Blood Oxygenator Sales by Country (Units), 2021–2026
Table 29. North America Blood Oxygenator Sales by Country (Units), 2027–2032
Table 30. North America Blood Oxygenator Revenue by Country (US$ Million), 2021–2026
Table 31. North America Blood Oxygenator Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Blood Oxygenator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Blood Oxygenator Sales by Country (Units), 2021–2026
Table 34. Europe Blood Oxygenator Sales by Country (Units), 2027–2032
Table 35. Europe Blood Oxygenator Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Blood Oxygenator Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Blood Oxygenator Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Blood Oxygenator Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Blood Oxygenator Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Blood Oxygenator Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Blood Oxygenator Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Blood Oxygenator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Blood Oxygenator Sales by Country (Units), 2021–2026
Table 44. Latin America Blood Oxygenator Sales by Country (Units), 2027–2032
Table 45. Latin America Blood Oxygenator Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Blood Oxygenator Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Blood Oxygenator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Blood Oxygenator Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Blood Oxygenator Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Blood Oxygenator Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Blood Oxygenator Revenue by Country (US$ Million), 2027–2032
Table 52. Global Blood Oxygenator Sales (Units) by Type (2021–2026)
Table 53. Global Blood Oxygenator Sales (Units) by Type (2027–2032)
Table 54. Global Blood Oxygenator Sales Market Share by Type (2021–2026)
Table 55. Global Blood Oxygenator Sales Market Share by Type (2027–2032)
Table 56. Global Blood Oxygenator Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Blood Oxygenator Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Blood Oxygenator Revenue Market Share by Type (2021–2026)
Table 59. Global Blood Oxygenator Revenue Market Share by Type (2027–2032)
Table 60. Global Blood Oxygenator Price (US$/Unit) by Type (2021–2026)
Table 61. Global Blood Oxygenator Price (US$/Unit) by Type (2027–2032)
Table 62. Global Blood Oxygenator Sales (Units) by Application (2021–2026)
Table 63. Global Blood Oxygenator Sales (Units) by Application (2027–2032)
Table 64. Global Blood Oxygenator Sales Market Share by Application (2021–2026)
Table 65. Global Blood Oxygenator Sales Market Share by Application (2027–2032)
Table 66. Global Blood Oxygenator Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Blood Oxygenator Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Blood Oxygenator Revenue Market Share by Application (2021–2026)
Table 69. Global Blood Oxygenator Revenue Market Share by Application (2027–2032)
Table 70. Global Blood Oxygenator Price (US$/Unit) by Application (2021–2026)
Table 71. Global Blood Oxygenator Price (US$/Unit) by Application (2027–2032)
Table 72. Medtronic plc Company Information
Table 73. Medtronic plc Description and Business Overview
Table 74. Medtronic plc Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Medtronic plc Blood Oxygenator Product
Table 76. Medtronic plc Recent Developments/Updates
Table 77. Terumo Corporation Company Information
Table 78. Terumo Corporation Description and Business Overview
Table 79. Terumo Corporation Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Terumo Corporation Blood Oxygenator Product
Table 81. Terumo Corporation Recent Developments/Updates
Table 82. LivaNova PLC Company Information
Table 83. LivaNova PLC Description and Business Overview
Table 84. LivaNova PLC Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. LivaNova PLC Blood Oxygenator Product
Table 86. LivaNova PLC Recent Developments/Updates
Table 87. Getinge AB Company Information
Table 88. Getinge AB Description and Business Overview
Table 89. Getinge AB Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Getinge AB Blood Oxygenator Product
Table 91. Getinge AB Recent Developments/Updates
Table 92. Fresenius Medical Care AG Company Information
Table 93. Fresenius Medical Care AG Description and Business Overview
Table 94. Fresenius Medical Care AG Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Fresenius Medical Care AG Blood Oxygenator Product
Table 96. Fresenius Medical Care AG Recent Developments/Updates
Table 97. Eurosets S.r.l. Company Information
Table 98. Eurosets S.r.l. Description and Business Overview
Table 99. Eurosets S.r.l. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Eurosets S.r.l. Blood Oxygenator Product
Table 101. Eurosets S.r.l. Recent Developments/Updates
Table 102. Nipro Corporation Company Information
Table 103. Nipro Corporation Description and Business Overview
Table 104. Nipro Corporation Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Nipro Corporation Blood Oxygenator Product
Table 106. Nipro Corporation Recent Developments/Updates
Table 107. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Company Information
Table 108. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Description and Business Overview
Table 109. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood Oxygenator Product
Table 111. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Recent Developments/Updates
Table 112. Spectrum Medical S.r.l. Company Information
Table 113. Spectrum Medical S.r.l. Description and Business Overview
Table 114. Spectrum Medical S.r.l. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Spectrum Medical S.r.l. Blood Oxygenator Product
Table 116. Spectrum Medical S.r.l. Recent Developments/Updates
Table 117. Dongguan Kewei Medical Instrument Co., Ltd. Company Information
Table 118. Dongguan Kewei Medical Instrument Co., Ltd. Description and Business Overview
Table 119. Dongguan Kewei Medical Instrument Co., Ltd. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Dongguan Kewei Medical Instrument Co., Ltd. Blood Oxygenator Product
Table 121. Dongguan Kewei Medical Instrument Co., Ltd. Recent Developments/Updates
Table 122. Shenzhen Lifemotion Medical Technology Co., Ltd. Company Information
Table 123. Shenzhen Lifemotion Medical Technology Co., Ltd. Description and Business Overview
Table 124. Shenzhen Lifemotion Medical Technology Co., Ltd. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Shenzhen Lifemotion Medical Technology Co., Ltd. Blood Oxygenator Product
Table 126. Shenzhen Lifemotion Medical Technology Co., Ltd. Recent Developments/Updates
Table 127. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Company Information
Table 128. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Description and Business Overview
Table 129. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood Oxygenator Product
Table 131. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Recent Developments/Updates
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Blood Oxygenator Distributors List
Table 135. Blood Oxygenator Customers List
Table 136. Blood Oxygenator Market Trends
Table 137. Blood Oxygenator Market Drivers
Table 138. Blood Oxygenator Market Challenges
Table 139. Blood Oxygenator Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Authors List of This Report
List of Figures
Figure 1. Product Picture of Blood Oxygenator
Figure 2. Global Blood Oxygenator Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Blood Oxygenator Market Share by Type: 2025 & 2032
Figure 4. Cardiopulmonary Bypass Oxygenators Product Picture
Figure 5. Extracorporeal Membrane Oxygenation Oxygenators Product Picture
Figure 6. Others Product Picture
Figure 7. Global Blood Oxygenator Market Value by Support Duration (US$ Million), 2021–2032
Figure 8. Global Blood Oxygenator Market Share by Support Duration: 2025 vs 2032
Figure 9. Short-Term Oxygenators Up to 6 Hours Product Picture
Figure 10. Long-Term Oxygenators Over 6 Hours Product Picture
Figure 11. Global Blood Oxygenator Market Value by Membrane Material (US$ Million), 2021–2032
Figure 12. Global Blood Oxygenator Market Share by Membrane Material: 2025 vs 2032
Figure 13. Microporous Polypropylene Oxygenators Product Picture
Figure 14. Polymethylpentene Oxygenators Product Picture
Figure 15. Others Product Picture
Figure 16. Global Blood Oxygenator Market Value by Application (US$ Million), 2021–2032
Figure 17. Global Blood Oxygenator Market Share by Application: 2025 & 2032
Figure 18. Adult Oxygenators
Figure 19. Pediatric and Neonatal Oxygenators
Figure 20. Global Blood Oxygenator Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Blood Oxygenator Market Size (US$ Million), 2021–2032
Figure 22. Global Blood Oxygenator Sales (Units), 2021–2032
Figure 23. Global Blood Oxygenator Average Price (US$/Unit), 2021–2032
Figure 24. Blood Oxygenator Report Years Considered
Figure 25. Blood Oxygenator Sales Share by Manufacturers in 2025
Figure 26. Global Blood Oxygenator Revenue Share by Manufacturers in 2025
Figure 27. Top 5 and Top 10 Global Blood Oxygenator Players: Market Share by Revenue in Blood Oxygenator in 2025
Figure 28. Blood Oxygenator Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 29. Global Blood Oxygenator Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 30. North America Blood Oxygenator Sales Market Share by Country (2021–2032)
Figure 31. North America Blood Oxygenator Revenue Market Share by Country (2021–2032)
Figure 32. U.S. Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Canada Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Europe Blood Oxygenator Sales Market Share by Country (2021–2032)
Figure 35. Europe Blood Oxygenator Revenue Market Share by Country (2021–2032)
Figure 36. Germany Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. France Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. U.K. Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Italy Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Russia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Asia Pacific Blood Oxygenator Sales Market Share by Region (2021–2032)
Figure 42. Asia Pacific Blood Oxygenator Revenue Market Share by Region (2021–2032)
Figure 43. China Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Japan Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. South Korea Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. India Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Australia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Taiwan Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Indonesia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Thailand Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Malaysia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Philippines Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Blood Oxygenator Sales Market Share by Country (2021–2032)
Figure 54. Latin America Blood Oxygenator Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Blood Oxygenator Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Blood Oxygenator Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. U.A.E Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Blood Oxygenator by Type (2021–2032)
Figure 64. Global Revenue Market Share of Blood Oxygenator by Type (2021–2032)
Figure 65. Global Blood Oxygenator Price (US$/Unit) by Type (2021–2032)
Figure 66. Global Sales Market Share of Blood Oxygenator by Application (2021–2032)
Figure 67. Global Revenue Market Share of Blood Oxygenator by Application (2021–2032)
Figure 68. Global Blood Oxygenator Price (US$/Unit) by Application (2021–2032)
Figure 69. Blood Oxygenator Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Blood Oxygenator Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Blood Oxygenator Market Value by Support Duration (US$ Million), 2025 vs 2032
Table 3. Global Blood Oxygenator Market Value by Membrane Material (US$ Million), 2025 vs 2032
Table 4. Global Blood Oxygenator Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Blood Oxygenator Market Competitive Situation by Manufacturers in 2025
Table 6. Global Blood Oxygenator Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Blood Oxygenator Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Blood Oxygenator Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Blood Oxygenator Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Blood Oxygenator Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Blood Oxygenator, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Blood Oxygenator, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Blood Oxygenator, Product Types and Applications
Table 14. Global Key Manufacturers of Blood Oxygenator, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Blood Oxygenator Companies by Tier (Tier 1, Tier 2, Tier 3), based on Blood Oxygenator Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Blood Oxygenator Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Blood Oxygenator Sales by Region (Units), 2021–2026
Table 20. Global Blood Oxygenator Sales Market Share by Region (2021–2026)
Table 21. Global Blood Oxygenator Sales by Region (Units), 2027–2032
Table 22. Global Blood Oxygenator Sales Market Share by Region (2027–2032)
Table 23. Global Blood Oxygenator Revenue by Region (US$ Million), 2021–2026
Table 24. Global Blood Oxygenator Revenue Market Share by Region (2021–2026)
Table 25. Global Blood Oxygenator Revenue by Region (US$ Million), 2027–2032
Table 26. Global Blood Oxygenator Revenue Market Share by Region (2027–2032)
Table 27. North America Blood Oxygenator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Blood Oxygenator Sales by Country (Units), 2021–2026
Table 29. North America Blood Oxygenator Sales by Country (Units), 2027–2032
Table 30. North America Blood Oxygenator Revenue by Country (US$ Million), 2021–2026
Table 31. North America Blood Oxygenator Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Blood Oxygenator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Blood Oxygenator Sales by Country (Units), 2021–2026
Table 34. Europe Blood Oxygenator Sales by Country (Units), 2027–2032
Table 35. Europe Blood Oxygenator Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Blood Oxygenator Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Blood Oxygenator Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Blood Oxygenator Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Blood Oxygenator Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Blood Oxygenator Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Blood Oxygenator Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Blood Oxygenator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Blood Oxygenator Sales by Country (Units), 2021–2026
Table 44. Latin America Blood Oxygenator Sales by Country (Units), 2027–2032
Table 45. Latin America Blood Oxygenator Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Blood Oxygenator Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Blood Oxygenator Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Blood Oxygenator Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Blood Oxygenator Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Blood Oxygenator Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Blood Oxygenator Revenue by Country (US$ Million), 2027–2032
Table 52. Global Blood Oxygenator Sales (Units) by Type (2021–2026)
Table 53. Global Blood Oxygenator Sales (Units) by Type (2027–2032)
Table 54. Global Blood Oxygenator Sales Market Share by Type (2021–2026)
Table 55. Global Blood Oxygenator Sales Market Share by Type (2027–2032)
Table 56. Global Blood Oxygenator Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Blood Oxygenator Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Blood Oxygenator Revenue Market Share by Type (2021–2026)
Table 59. Global Blood Oxygenator Revenue Market Share by Type (2027–2032)
Table 60. Global Blood Oxygenator Price (US$/Unit) by Type (2021–2026)
Table 61. Global Blood Oxygenator Price (US$/Unit) by Type (2027–2032)
Table 62. Global Blood Oxygenator Sales (Units) by Application (2021–2026)
Table 63. Global Blood Oxygenator Sales (Units) by Application (2027–2032)
Table 64. Global Blood Oxygenator Sales Market Share by Application (2021–2026)
Table 65. Global Blood Oxygenator Sales Market Share by Application (2027–2032)
Table 66. Global Blood Oxygenator Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Blood Oxygenator Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Blood Oxygenator Revenue Market Share by Application (2021–2026)
Table 69. Global Blood Oxygenator Revenue Market Share by Application (2027–2032)
Table 70. Global Blood Oxygenator Price (US$/Unit) by Application (2021–2026)
Table 71. Global Blood Oxygenator Price (US$/Unit) by Application (2027–2032)
Table 72. Medtronic plc Company Information
Table 73. Medtronic plc Description and Business Overview
Table 74. Medtronic plc Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Medtronic plc Blood Oxygenator Product
Table 76. Medtronic plc Recent Developments/Updates
Table 77. Terumo Corporation Company Information
Table 78. Terumo Corporation Description and Business Overview
Table 79. Terumo Corporation Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Terumo Corporation Blood Oxygenator Product
Table 81. Terumo Corporation Recent Developments/Updates
Table 82. LivaNova PLC Company Information
Table 83. LivaNova PLC Description and Business Overview
Table 84. LivaNova PLC Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. LivaNova PLC Blood Oxygenator Product
Table 86. LivaNova PLC Recent Developments/Updates
Table 87. Getinge AB Company Information
Table 88. Getinge AB Description and Business Overview
Table 89. Getinge AB Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Getinge AB Blood Oxygenator Product
Table 91. Getinge AB Recent Developments/Updates
Table 92. Fresenius Medical Care AG Company Information
Table 93. Fresenius Medical Care AG Description and Business Overview
Table 94. Fresenius Medical Care AG Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. Fresenius Medical Care AG Blood Oxygenator Product
Table 96. Fresenius Medical Care AG Recent Developments/Updates
Table 97. Eurosets S.r.l. Company Information
Table 98. Eurosets S.r.l. Description and Business Overview
Table 99. Eurosets S.r.l. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Eurosets S.r.l. Blood Oxygenator Product
Table 101. Eurosets S.r.l. Recent Developments/Updates
Table 102. Nipro Corporation Company Information
Table 103. Nipro Corporation Description and Business Overview
Table 104. Nipro Corporation Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Nipro Corporation Blood Oxygenator Product
Table 106. Nipro Corporation Recent Developments/Updates
Table 107. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Company Information
Table 108. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Description and Business Overview
Table 109. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Blood Oxygenator Product
Table 111. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD. Recent Developments/Updates
Table 112. Spectrum Medical S.r.l. Company Information
Table 113. Spectrum Medical S.r.l. Description and Business Overview
Table 114. Spectrum Medical S.r.l. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. Spectrum Medical S.r.l. Blood Oxygenator Product
Table 116. Spectrum Medical S.r.l. Recent Developments/Updates
Table 117. Dongguan Kewei Medical Instrument Co., Ltd. Company Information
Table 118. Dongguan Kewei Medical Instrument Co., Ltd. Description and Business Overview
Table 119. Dongguan Kewei Medical Instrument Co., Ltd. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Dongguan Kewei Medical Instrument Co., Ltd. Blood Oxygenator Product
Table 121. Dongguan Kewei Medical Instrument Co., Ltd. Recent Developments/Updates
Table 122. Shenzhen Lifemotion Medical Technology Co., Ltd. Company Information
Table 123. Shenzhen Lifemotion Medical Technology Co., Ltd. Description and Business Overview
Table 124. Shenzhen Lifemotion Medical Technology Co., Ltd. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Shenzhen Lifemotion Medical Technology Co., Ltd. Blood Oxygenator Product
Table 126. Shenzhen Lifemotion Medical Technology Co., Ltd. Recent Developments/Updates
Table 127. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Company Information
Table 128. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Description and Business Overview
Table 129. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood Oxygenator Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Blood Oxygenator Product
Table 131. Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. Recent Developments/Updates
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Blood Oxygenator Distributors List
Table 135. Blood Oxygenator Customers List
Table 136. Blood Oxygenator Market Trends
Table 137. Blood Oxygenator Market Drivers
Table 138. Blood Oxygenator Market Challenges
Table 139. Blood Oxygenator Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Authors List of This Report
List of Figures
Figure 1. Product Picture of Blood Oxygenator
Figure 2. Global Blood Oxygenator Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Blood Oxygenator Market Share by Type: 2025 & 2032
Figure 4. Cardiopulmonary Bypass Oxygenators Product Picture
Figure 5. Extracorporeal Membrane Oxygenation Oxygenators Product Picture
Figure 6. Others Product Picture
Figure 7. Global Blood Oxygenator Market Value by Support Duration (US$ Million), 2021–2032
Figure 8. Global Blood Oxygenator Market Share by Support Duration: 2025 vs 2032
Figure 9. Short-Term Oxygenators Up to 6 Hours Product Picture
Figure 10. Long-Term Oxygenators Over 6 Hours Product Picture
Figure 11. Global Blood Oxygenator Market Value by Membrane Material (US$ Million), 2021–2032
Figure 12. Global Blood Oxygenator Market Share by Membrane Material: 2025 vs 2032
Figure 13. Microporous Polypropylene Oxygenators Product Picture
Figure 14. Polymethylpentene Oxygenators Product Picture
Figure 15. Others Product Picture
Figure 16. Global Blood Oxygenator Market Value by Application (US$ Million), 2021–2032
Figure 17. Global Blood Oxygenator Market Share by Application: 2025 & 2032
Figure 18. Adult Oxygenators
Figure 19. Pediatric and Neonatal Oxygenators
Figure 20. Global Blood Oxygenator Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Blood Oxygenator Market Size (US$ Million), 2021–2032
Figure 22. Global Blood Oxygenator Sales (Units), 2021–2032
Figure 23. Global Blood Oxygenator Average Price (US$/Unit), 2021–2032
Figure 24. Blood Oxygenator Report Years Considered
Figure 25. Blood Oxygenator Sales Share by Manufacturers in 2025
Figure 26. Global Blood Oxygenator Revenue Share by Manufacturers in 2025
Figure 27. Top 5 and Top 10 Global Blood Oxygenator Players: Market Share by Revenue in Blood Oxygenator in 2025
Figure 28. Blood Oxygenator Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 29. Global Blood Oxygenator Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 30. North America Blood Oxygenator Sales Market Share by Country (2021–2032)
Figure 31. North America Blood Oxygenator Revenue Market Share by Country (2021–2032)
Figure 32. U.S. Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Canada Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Europe Blood Oxygenator Sales Market Share by Country (2021–2032)
Figure 35. Europe Blood Oxygenator Revenue Market Share by Country (2021–2032)
Figure 36. Germany Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. France Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. U.K. Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Italy Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Russia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Asia Pacific Blood Oxygenator Sales Market Share by Region (2021–2032)
Figure 42. Asia Pacific Blood Oxygenator Revenue Market Share by Region (2021–2032)
Figure 43. China Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Japan Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. South Korea Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. India Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Australia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Taiwan Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Indonesia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Thailand Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Malaysia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Philippines Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Blood Oxygenator Sales Market Share by Country (2021–2032)
Figure 54. Latin America Blood Oxygenator Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Blood Oxygenator Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Blood Oxygenator Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. U.A.E Blood Oxygenator Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Blood Oxygenator by Type (2021–2032)
Figure 64. Global Revenue Market Share of Blood Oxygenator by Type (2021–2032)
Figure 65. Global Blood Oxygenator Price (US$/Unit) by Type (2021–2032)
Figure 66. Global Sales Market Share of Blood Oxygenator by Application (2021–2032)
Figure 67. Global Revenue Market Share of Blood Oxygenator by Application (2021–2032)
Figure 68. Global Blood Oxygenator Price (US$/Unit) by Application (2021–2032)
Figure 69. Blood Oxygenator Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Physical Graphing Calculators Market Research Report 2026
Nov 14, 26
Global Graphics Calculators Market Research Report 2026
Nov 14, 26
Global Internet and Wi-fi Connected Smart Dishwashers Market Research Report 2026
Nov 14, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232